Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)
19/08/2021 13:00
Grande área: Biológicas / Saúde
Tipo de oportunidade: Bolsa
Objetivo: To support research which can elucidate mechanism(s) of action by which gut microbes inhibit or enhance anti-tumor immune responses. Thus, research projects should be focused on delineating how specific microbes or their metabolites target host immune responses to prevent colitis-associated or sporadic tumor formation.
Inscrições: até 11 de setembro de 2021
Local: Estados Unidos
Mais informações no site.
